These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 6221609)

  • 41. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
    Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
    Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.
    Honn KV
    Clin Exp Metastasis; 1983; 1(2):103-14. PubMed ID: 6242706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.
    Fidler IJ
    J Natl Cancer Inst; 1970 Oct; 45(4):773-82. PubMed ID: 5513503
    [No Abstract]   [Full Text] [Related]  

  • 44. Prostacyclin in the cardiovascular system.
    Moncada S; Vane JR
    Adv Prostaglandin Thromboxane Res; 1980; 6():43-60. PubMed ID: 6992536
    [No Abstract]   [Full Text] [Related]  

  • 45. Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients.
    Strano A; Davì G; Averna M; Rini GB; Novo S; Di Fede G; Mattina A; Notarbartolo A
    Thromb Haemost; 1982 Aug; 48(1):18-20. PubMed ID: 6753232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cancer blood-borne metastasis and platelets].
    Tanaka K; Fukumoto S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological properties of prostacyclin-thromboxane system.
    Blaskó G
    Ther Hung; 1984; 32(2):45-51. PubMed ID: 6443751
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prostanoids (prostaglandins, thromboxanes, prostacyclin) and leukotrienes].
    Kecskeméti V
    Orv Hetil; 1983 Dec; 124(49):2967-74. PubMed ID: 6318174
    [No Abstract]   [Full Text] [Related]  

  • 49. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of plasma protease inhibitors on tumor cell-induced platelet aggregation.
    Pacchiarini L; Pagliarino M; Rota Scalabrini D; Grignani G; Rizzo SC
    Haematologica; 1986; 71(3):269. PubMed ID: 3093335
    [No Abstract]   [Full Text] [Related]  

  • 51. Antimetastatic and antitumor effect of platelet aggregation inhibitors.
    Ambrus JL; Ambrus CM; Gastpar H; Huberman E; Montagna R; Biddle W; Leong S; Horoszewicz J
    Prog Clin Biol Res; 1982; 89():97-111. PubMed ID: 7111312
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prostacyclin; clinical aspects].
    Sitsen JM; Nijkamp FP
    Ned Tijdschr Geneeskd; 1983 Jan; 127(5):199-206. PubMed ID: 6338406
    [No Abstract]   [Full Text] [Related]  

  • 53. Prostaglandins and platelet function.
    Chaikhouni A
    J S C Med Assoc; 1983 Jun; 79(6):332-6. PubMed ID: 6350704
    [No Abstract]   [Full Text] [Related]  

  • 54. Prostaglandins and thromboxanes.
    Samuelsson B
    Recent Prog Horm Res; 1978; 34():239-58. PubMed ID: 366681
    [No Abstract]   [Full Text] [Related]  

  • 55. Prostaglandins in vascular disease: a seminal approach.
    Mitchell JR
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):590-4. PubMed ID: 6781584
    [No Abstract]   [Full Text] [Related]  

  • 56. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor.
    Murata T; Ushikubi F; Matsuoka T; Hirata M; Yamasaki A; Sugimoto Y; Ichikawa A; Aze Y; Tanaka T; Yoshida N; Ueno A; Oh-ishi S; Narumiya S
    Nature; 1997 Aug; 388(6643):678-82. PubMed ID: 9262402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostacyclin in physiology and pathophysiology.
    Vane JR; Bunting S; Moncada S
    Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent observations on the pathogenesis of cancer metastasis.
    Fidler IJ; Hart IR
    Prog Clin Biol Res; 1982; 85 Pt B():601-19. PubMed ID: 6750636
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacology of prostacyclin and prostacyclin-like compounds].
    Lakin KM; Baluda VP; Makarov VA
    Vestn Akad Med Nauk SSSR; 1982; (5):81-91. PubMed ID: 7048789
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostaglandins and coronary circulation.
    Vapaatalo H
    Acta Med Scand Suppl; 1985; 694():45-54. PubMed ID: 3890471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.